9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
MRK Coverage Page 22
10:30am ET
Health and Healthcare
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Chris Lange 10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
6:20am ET
Investing
4 Conservative Merrill Lynch US 1 Stock Picks That Pay Reliable Dividends
These four outstanding ideas from the US 1 team at Merrill Lynch are decidedly more conservative than most of the list's holdings, but they offer investors excellent total return potential and a…
9:55am ET
Health and Healthcare
Will This Ebola Vaccine Be the Next Big Thing?
NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola vaccine.
Chris Lange 7:11am ET
Investing
As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus
As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked ESG companies. Imagine also what could happen to some of the companies…
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:05am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More
The top analyst upgrades, downgrades and initiations on Friday included Alibaba, Amgen, Applied Materials, Intel, Merck, Nvidia and Walmart.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
8:40am ET
Health and Healthcare
Major Pharma Sees Rising Tide in Short Interest
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Arconic, Boston Beer, Disney, Dunkin’, DuPont, GreenSky, IFF, Merck and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Arconic, Boston Beer, Dunkin' Brands, DuPont, GreenSky, International Flavors & Fragrances, Merck and Walt Disney.
9:40am ET
Health and Healthcare
Why Keytruda Made All the Difference in Merck’s Q2
Merck released better than expected second-quarter financial results before the markets opened on Tuesday.
Chris Lange 12:05pm ET
Health and Healthcare
What to Watch When Merck and Pfizer Report Early on Tuesday
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make…